YAP1 and autoimmune hepatitis: In conclusion, these findings demonstrate that the Hippo-YAP signaling pathway, the immune microenvironment balance of MDSCs and T cells can serve as a possible key target for AIH therapy, which provides new insights into the therapeutic potential of GSS in the treatment of AIH.